Are targeted therapies really targeted?
Schilsky
Richard L
RL
University of Chicago, IL, USA.
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000191:economics; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D006801:Humans; D009363:Neoplasm Proteins / Q000187:drug effects / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins